Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - doxycycline hydrochloride 115mg equivalent to doxycycline 100 mg - capsule - 100 mg - active: doxycycline hydrochloride 115mg equivalent to doxycycline 100 mg excipient: brilliant blue fcf gelatin magnesium stearate microcrystalline cellulose quinoline yellow titanium dioxide

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - doxycycline hydrochloride 115mg equivalent to doxycycline 100mg - film coated tablet - 100 mg - active: doxycycline hydrochloride 115mg equivalent to doxycycline 100mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry yellow oy-ls-32814 pregelatinised maize starch purified water - doxycycline is indicated in the treatment of uncomplicated chest, urethral, endocervical or rectal infections in adults caused by susceptible organisms as shown by culture and sensitivity testing. it may also be a useful adjunct to amoebicides in acute intestinal amoebiasis and has a place as adjunctive therapy in severe acne.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

chartwell rx llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae . - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . - trachoma caused by chlamydia trachomatis, although the infectious agent is not always el

Amerika Serikat - Inggris - NLM (National Library of Medicine)

chartwell governmental & specialty rx, llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 50 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae . - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci .

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxycycline hyclate, quantity: 115 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; quinoline yellow; macrogol 4000 - doxycycline is indicated in the treatment of infections caused by the following microorganisms: mycoplasma pneumoniae: primary atypical pneumonia; rickettsiae: queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus; chlamydia psittaci: psittacosis; calymmatobacterium (donovania) granulomatis: granuloma inguinale; chlamydia trachomatis: lymphogranuloma venereum, trachoma, inclusion conjunctivitis (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.); doxycycline is indicated in the treatment of infections caused by the following gram-negative microorganisms: vibrio species: cholera; brucella species: brucellosis (in conjunction with streptomycin); yersinia pestis: plague; francisella tularensis: tularaemia; bartonella bacilliformis: bartonellosis; bacteroides species. doxycycline is active against both pre-erythrocytic and asexual bloodstages of plasmodium falciparum. the tetracyclines are only partially active against the pre-erythrocytic stages of plasmodium vivax, and protection depends on drug suppression of the blood stages. doxycycline has no activity against the relapsing forms (hypnozoites) of plasmodium vivax. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p.vivax. as there are relatively few locations where p.vivax does not co-exist to some extent with p.falciparum, it is recommended that doxycycline should be used routinely with other agents, eg. chloroquine. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum: syphilis; treponema pertenue: yaws; neisseria gonorrhoeae: gonorrhoea. doxycycline may be a useful adjunct to amoebicides in the treatment of acute intestinal amoebiasis. in the treatment of severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is not the drug of choice in the following: any type of staphylococcal infection or infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis, or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxylin should not be used for these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci, (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

greenstone llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae. - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . - trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated, as jud

Amerika Serikat - Inggris - NLM (National Library of Medicine)

legacy pharmaceutical packaging - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: -  rocky mountain spotted fever, typhus fever and the typhus group, q. fever, rickettsialpox, and tick fevers caused by rickettsiae. -  respiratory tract infections caused by mycoplasma pneumoniae. -  lymphogranuloma venereum caused by chlamydia trachomatis. -  psittacosis (ornithosis) caused by chlamydia psittaci. -  trachoma caused by chlamydia trachomatis, although the infectious agent is not always eliminated as judg

Amerika Serikat - Inggris - NLM (National Library of Medicine)

rebel distributors corp. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms: because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline culture and susceptibility testing are recommended. doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates app

Amerika Serikat - Inggris - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 75 mg - doxycycline hyclate delayed-release tablets are indicated for treatment of rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. doxycycline hyclate delayed-release tablets are indicated for treatment of the following sexually transmitted infections: • uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis . • nongonococcal urethritis caused by ureaplasma urealyticum . • lymphogranuloma venereum caused by chlamydia trachomatis . • granuloma inguinale caused by klebsiella granulomatis . • uncomplicated gonorrhea caused by neisseria gonorrhoeae . • chancroid caused by haemophilus ducreyi . doxycycline hyclate delayed-release tablets are indicated for treatment of the following respiratory infections: • respiratory tract infections caused by mycoplasma pneumoniae . psittacosis (ornithosis) caused by chlamydophila psittaci . • because many strains of the following groups of microorganisms have bee

Amerika Serikat - Inggris - NLM (National Library of Medicine)

harris pharmaceutical, inc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 50 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae. - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . - trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated, as judg